News & Press Releases

Recent progress in therapeutics for amyotrophic lateral sclerosis (ALS) has spurred development and imbued the field of ALS with hope for more breakthroughs, yet substantial

The Access for All in ALS Consortium (ALL ALS) announced the successful enrollment of the first participant. Established in the autumn of 2023 with funding

ALS is a complex neurodegenerative disease, but the causes remain poorly understood and there are few effective therapies available. There is an urgent need for